MICROSCIENCE LTD has a total of 275 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United Kingdom, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are MICROBIOLOGICAL RES AUTHORITY, INTERCELL AG and QUEENSLAND INST MED RES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 113 | |
#2 | Australia | 25 | |
#3 | EPO (European Patent Office) | 19 | |
#4 | New Zealand | 19 | |
#5 | China | 14 | |
#6 | WIPO (World Intellectual Property Organization) | 12 | |
#7 | Republic of Korea | 10 | |
#8 | African Regional Industrial Property Organization | 7 | |
#9 | Canada | 7 | |
#10 | Norway | 6 | |
#11 | Brazil | 5 | |
#12 | Czechia | 5 | |
#13 | United States | 5 | |
#14 | Hungary | 4 | |
#15 | African Intellectual Property Organization | 4 | |
#16 | Poland | 4 | |
#17 | South Africa | 4 | |
#18 | EAPO (Eurasian Patent Organization) | 3 | |
#19 | Hong Kong | 3 | |
#20 | Israel | 3 | |
#21 | Morocco | 1 | |
#22 | Mexico | 1 | |
#23 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Dougan Gordon | 91 |
#2 | Santangelo Joseph David | 83 |
#3 | Lane Jonathan Douglas | 59 |
#4 | Hughes Martin John Glenton | 56 |
#5 | Moore Joanne Christine | 48 |
#6 | Dobson Richard James | 47 |
#7 | Feldman Robert | 47 |
#8 | Wilson Rebecca Kerry | 44 |
#9 | Everest Paul | 44 |
#10 | Holden David William | 42 |
Publication | Filing date | Title |
---|---|---|
AU2008200445A1 | Virulence genes, proteins, and their use | |
AU2007202896A1 | Genes and proteins, and their uses | |
AU2007200542A1 | Virulence genes and proteins, and their use | |
AU2007200004A1 | Genes and proteins, and their use | |
AU2004203417A1 | Virulence genes, proteins, and their use | |
AU2004201404A1 | Genes and proteins, and their use | |
AU2003236302B2 | Virulence genes and proteins, and their use | |
AU2003204710B2 | Attenuated microorganisms for the treatment of infection | |
AU2002304016B2 | Outer surface proteins, their genes, and their use | |
GB0208499D0 | Streptococcal genes | |
GB0208299D0 | Improved gene expression | |
US6890539B2 | Genes and proteins, and their use | |
GB0127657D0 | Virulence genes and proteins and their use | |
GB0126523D0 | Virulence genes, proteins, and their use | |
AU9203501A | Attenuated salmonella microorganisms comprising a mutation in the sifa gene | |
GB0123170D0 | Genes,proteins,and their use | |
GB0119802D0 | Mutant microorganisms | |
GB0108612D0 | Improved gene expression | |
GB0105922D0 | Genes and proteins, and their use | |
GB0105924D0 | Promoter |